↓
 

Gregory Glass

FDA Petitions

Gregory Glass
  • FDA Petitions Home
  • Editor’s Note
  • The Petition Process
  • FDA Petitions Database
    • Get Access
Home→Research Criteria and Technical Notes

Research Criteria and Technical Notes

FDA Petitions Home › FDA Petitions Database › Research Criteria and Technical Notes

  • This category has 4 topics.
    • Forum
    • Topics
    • Posts
    • Last Post
    • About FDAPetitions.com
      Research Criteria, Q&A
    • 3
    • 3
    • 14 years ago

      gregoryglass

    • Terms and Conditions
      The Subscription Agreement
    • 1
    • 1
    • 14 years ago

      Anonymous

  •  

Latest updates

Product: Metformin Extended-release Tablets
Company: Various
Petition Filer: Harmen Finochem
Petition Number(s): 2020P-1701
Date of Petition: July 27, 2020
Responding Petitions:

Issue and Implication: Whether FDA can designate a second Reference Standard when the current RS is in limited supply.

Action Requested by Petitioner: T…[Read more]

Profile picture of gregoryglass 2 weeks, 2 days ago

Product: Nipride RTU®(sodium nitroprusside) Injection
Company: Exela Pharma
Petition Filer: Cardinal Health
Petition Number(s): 2020P-1678
Date of Petition: July 20, 2020
Responding Petitions:

Action Requested by Petitioner: Petitioner is requesting FDA to determine whether Nipriode RTU®(sodium nitroprusside) Injection 10mg/50mL (…[Read more]

Profile picture of gregoryglass 3 weeks, 2 days ago

Product: Dobutrex®(dobutamine) Injection
Company: Eli Lilly
Petition Filer: Cardinal Health
Petition Number(s): 2020P-1650
Date of Petition: July 10, 2020
Responding Petitions:

Action Requested by Petitioner: The petitioner would like to FDA to determine whether Dobutrex®(dobutamine) Injection 12.5mg base/mL (NDA 017820) was r…[Read more]

Profile picture of gregoryglass 1 month ago
FDAPetitions.com™ is a trademark of Parry Ashford Inc. • ©Parry Ashford Inc. 2020
↑